Cann logo

CAN - Cann News Story

A$0.425 0.0  3.7%

Last Trade - 3:15am

Sector
Healthcare
Size
Micro Cap
Market Cap £32.4m
Enterprise Value £36.7m
Revenue £358k
Position in Universe 911th / 1828

BUZZ-Australia's medical cannabis sector has potential if regulation eases - Morgans

Tue 3rd December, 2019 4:50am
** Australia's medical cannabis sector is crowded and
difficult to navigate in the current regulatory environment but
there is "significant" potential for some if regulation eases,
Morgans says
    ** Differentiation levels, slow moving regulation, weak
clinical evidence of efficacy, and expensive treatment costs
make it a slower-moving proposition compared with traditional
drug assets - Morgans 
    ** On a 10-year view, high likelihood that the Australian
market may closely mirror U.S. and Canadian peers in terms of
regulation and recreational legalisation - broker
    ** In the meantime, dwindling cash reserves and negative
cashflows across ASX companies, especially pure-play stocks, are
a concern; sector makeup in will be vastly different in coming
years - Morgans 
    ** ASX-listed pot stocks include Auscann Group Holdings
 AC8.AX , Althea Group Holdings  AGH.AX , Cann Group  CAN.AX 
Cann Global  CGB.AX , Creso Pharma  CPH.AX  and others
    ** In Sept, Canberra became the first city in Australia to 
legalise possession, use and cultivation of small amounts of
cannabis  urn:newsml:reuters.com:*:nL3N26G2ER
    ** New Zealand will hold a referendum next year on
legalizing cannabis for personal use
    ** Patients are allowed to use medicinal cannabis products
in Australia only on the prescription of a doctor

 (Reporting by Nikhil Kurian Nainan)
 ((NikhilKurian.Nainan@thomsonreuters.com; Twitter:
@NikhilKurianN))
© Stockopedia 2020, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.